Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93


T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation.

Henrickson SE, Mempel TR, Mazo IB, Liu B, Artyomov MN, Zheng H, Peixoto A, Flynn MP, Senman B, Junt T, Wong HC, Chakraborty AK, von Andrian UH.

Nat Immunol. 2008 Mar;9(3):282-91. doi: 10.1038/ni1559. Epub 2008 Jan 20.


In vivo imaging of T cell priming.

Henrickson SE, Mempel TR, Mazo IB, Liu B, Artyomov MN, Zheng H, Peixoto A, Flynn M, Senman B, Junt T, Wong HC, Chakraborty AK, von Andrian UH.

Sci Signal. 2008 Mar 25;1(12):pt2. doi: 10.1126/stke.112pt2.


Antigen availability determines CD8⁺ T cell-dendritic cell interaction kinetics and memory fate decisions.

Henrickson SE, Perro M, Loughhead SM, Senman B, Stutte S, Quigley M, Alexe G, Iannacone M, Flynn MP, Omid S, Jesneck JL, Imam S, Mempel TR, Mazo IB, Haining WN, von Andrian UH.

Immunity. 2013 Sep 19;39(3):496-507. doi: 10.1016/j.immuni.2013.08.034.


Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes.

Skokos D, Shakhar G, Varma R, Waite JC, Cameron TO, Lindquist RL, Schwickert T, Nussenzweig MC, Dustin ML.

Nat Immunol. 2007 Aug;8(8):835-44. Epub 2007 Jul 15.


Immunodominance analysis through interactions of CD8+ T cells and DCs in lymph nodes.

Wu YU, Xia L, Zhang M, Zhao X.

Math Biosci. 2010 May;225(1):53-8. doi: 10.1016/j.mbs.2010.01.009. Epub 2010 Feb 4.


pMHC affinity controls duration of CD8+ T cell-DC interactions and imprints timing of effector differentiation versus expansion.

Ozga AJ, Moalli F, Abe J, Swoger J, Sharpe J, Zehn D, Kreutzfeldt M, Merkler D, Ripoll J, Stein JV.

J Exp Med. 2016 Nov 14;213(12):2811-2829. Epub 2016 Oct 31.


Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo.

Ramelli G, Fuertes S, Narayan S, Busso N, Acha-Orbea H, So A.

Immunology. 2010 Jan;129(1):20-7. doi: 10.1111/j.1365-2567.2009.03144.x. Epub 2009 Jun 22.


Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.

Bosch B, Heipertz EL, Drake JR, Roche PA.

J Biol Chem. 2013 May 10;288(19):13236-42. doi: 10.1074/jbc.M112.442640. Epub 2013 Mar 26.


How antigen quantity and quality determine T-cell decisions in lymphoid tissue.

Zheng H, Jin B, Henrickson SE, Perelson AS, von Andrian UH, Chakraborty AK.

Mol Cell Biol. 2008 Jun;28(12):4040-51. doi: 10.1128/MCB.00136-08. Epub 2008 Apr 21.


The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge.

Carreño LJ, Bueno SM, Bull P, Nathenson SG, Kalergis AM.

Immunology. 2007 Jun;121(2):227-37. Epub 2007 Feb 20.


Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.

Li Q, Grover AC, Donald EJ, Carr A, Yu J, Whitfield J, Nelson M, Takeshita N, Chang AE.

J Immunol. 2005 Aug 1;175(3):1424-32.


Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ.

Inaba K, Metlay JP, Crowley MT, Steinman RM.

J Exp Med. 1990 Aug 1;172(2):631-40. Erratum in: J Exp Med 1990 Oct 1;172(4):1275.


T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.

Mempel TR, Henrickson SE, Von Andrian UH.

Nature. 2004 Jan 8;427(6970):154-9.


Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells.

Koyama M, Hashimoto D, Aoyama K, Matsuoka K, Karube K, Niiro H, Harada M, Tanimoto M, Akashi K, Teshima T.

Blood. 2009 Feb 26;113(9):2088-95. doi: 10.1182/blood-2008-07-168609. Epub 2009 Jan 14.


CD4+ Th-APC with acquired peptide/MHC class I and II complexes stimulate type 1 helper CD4+ and central memory CD8+ T cell responses.

Umeshappa CS, Huang H, Xie Y, Wei Y, Mulligan SJ, Deng Y, Xiang J.

J Immunol. 2009 Jan 1;182(1):193-206.


Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses.

Chappell CP, Draves KE, Giltiay NV, Clark EA.

J Exp Med. 2012 Sep 24;209(10):1825-40. Epub 2012 Sep 10.

Supplemental Content

Support Center